RobinKDoreMD

PubMed

• Associations of Cost Sharing With Rheumatoid Arthritis Disease Burden.
  Sharon Dowell, Christopher J Swearingen, Manuela Pedra-Nobre, Dianne Wollaston, Sawsan Najmey, Cynthia Lawrence Elliott, Theresa Lawrence Ford, Heather North, Robin Do...> ;ACR Open Rheumatology. 2023 Aug 1
• 1 citations
  Geographic Variation in Disease Burden and Mismatch in Care of Patients With Rheumatoid Arthritis in the United States.
  Sharon Dowell, Huifeng Yun, Jeffrey R Curtis, Lang Chen, Fenglong Xie, Manuela Pedra-Nobre, Dianne Wollaston, Sawsan Najmey, Cynthia Lawrence Elliott, Theresa Lawrence...> ;ACR Open Rheumatology. 2023 Apr 1
• 3 citations
  The Incidence, Prevalence, and Associated Costs of Anemia, Malignancy, Venous Thromboembolism, Major Adverse Cardiovascular Events, and Infections in Rheumatoid Arthri...
  Robin K. Dore, Jenya Antonova, Chakkarin Burudpakdee, Lawrence Chang, Magdaliz Gorritz, Mark C. Genovese> ;ACR Open Rheumatology. 2021 Nov 18
• 2 citations
  Forearm bone mineral density and fracture incidence in postmenopausal women with osteoporosis: results from the ACTIVExtend phase 3 trial.
  Nelson B. Watts, Robin K. Dore, Sanford Baim, Bruce H. Mitlak, Gary Hattersley, Yamei Wang, Tamara D. Rozental, Meryl S. LeBoff> ;Osteoporosis International. 2021 Jan 1
• 11 citations
  Fracture and Bone Mineral Density Response by Baseline Risk in Patients Treated With Abaloparatide Followed by Alendronate: Results From the Phase 3 ACTIVExtend Trial.
  Benjamin Z. Leder, Carol Zapalowski, Ming Yi Hu, Gary Hattersley, Nancy E Lane, Andrea Singer, Robin K. Dore> ;Journal of Bone and Mineral Research. 2019 Dec 1
• 101 citations
  ACTIVExtend: 24 Months of Alendronate After 18 Months of Abaloparatide or Placebo for Postmenopausal Osteoporosis
  Henry G. Bone, Felicia Cosman, Paul D. Miller, Gregory C. Williams, Gary Hattersley, Ming-yi Hu, Lorraine A. Fitzpatrick, Bruce H. Mitlak, S. Papapoulos, René Rizzoli,...> ;The Journal of Clinical Endocrinology and Metabolism. 2018 Aug 1
• 1 citations
  Clinical utility of etanercept in the treatment of arthritides in children and adolescents.
  Robin K. Dore> ;Adolescent Health, Medicine and Therapeutics. 2014 Mar 26
• Should healthy people take calcium and vitamin D to prevent fractures? What the US Preventive Services Task Force and others say.
  Robin K. Dore> ;Cleveland Clinic Journal of Medicine. 2013 Jun 1
• 11 citations
  Long-term safety, efficacy, and patient acceptability of teriparatide in the management of glucocorticoid-induced osteoporosis
  Robin K. Dore> ;Patient Preference and Adherence. 2013 May 20
• 4 citations
  Data from Extension Trials: Denosumab and Zoledronic Acid
  Robin K. Dore> ;Current Osteoporosis Reports. 2012 Mar 1
• 21 citations
  The RANKL pathway and denosumab.
  Robin K. Dore> ;Rheumatic Diseases Clinics of North America. 2011 Aug 1
• 23 citations
  How to prevent glucocorticoid-induced osteoporosis.
  Robin K. Dore> ;Cleveland Clinic Journal of Medicine. 2010 Aug 1
• 128 citations
  Effects of denosumab on bone mineral density and bone turnover in patients with rheumatoid arthritis receiving concurrent glucocorticoids or bisphosphonates
  Robin K. Dore, Stanley Cohen, Nancy E Lane, William R Palmer, William Shergy, L. Zhou, H. Wang, Wayne Tsuji, Richard Newmark> ;Annals of the Rheumatic Diseases. 2010 May 1
• Denosumab-mediated increase in hand bone mineral density associated with decreased progression of bone erosion in rheumatoid arthritis patients.
  Deodhar, A., Dore, R. K., Mandel, D., Schechtman, J., Shergy, W., Trapp, R., Ory, P. A., Peterfy, C. G., Fuerst, T., Wang, H., Zhou, L., Tsuji, W., Newmark, R.> ;Arthritis Care Res (Hoboken). 2010 Apr
• 3 citations
  Patient experience with a new teriparatide delivery device.
  Robin K Dore, Robert G Feldman, Kathleen A. Taylor, Kyoungah See, Gail P Dalsky, Margaret R. Warner> ;Current Medical Research and Opinion. 2009 Sep 14
• 7 citations
  Gout: what primary care physicians want to know.
  Robin K. Dore> ;Journal of Clinical Rheumatology. 2008 Oct 1
• 13 citations
  The gout diagnosis.
  Robin K. Dore> ;Cleveland Clinic Journal of Medicine. 2008 Jul 1
• 407 citations
  Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: a twelve-month, multicenter, randomized, double-blin...
  Stanley Cohen, Robin K. Dore, Nancy E Lane, Peter A. Ory, Charles G. Peterfy, John T. Sharp, Désirée Van Der Heijde, L. Zhou, Wayne Tsuji, Richard Newmark> ;Arthritis and Rheumatism. 2008 May 1
• 30 citations
  Gastrointestinal tolerability of etoricoxib in rheumatoid arthritis patients: results of the etoricoxib vs diclofenac sodium gastrointestinal tolerability and effectiv...
  Klaus Krueger, Leticia Lino, Robin Dore, Sebastião Cezar Radominski, Yanqiong Zhang, Amarjot Kaur, Roger Simpson, Sean P. Curtis> ;Annals of the Rheumatic Diseases. 2007 Oct 27
• 120 citations
  The immunogenicity, safety, and efficacy of etanercept liquid administered once weekly in patients with rheumatoid arthritis.
  R. K. Dore, Mathews S, J. Schechtman, Surbeck W, D. Mandel, Patel A, L. Zhou, Peloso P> ;Clinical and Experimental Rheumatology. 2007 Jan 1
• 42 citations
  Reduction in the risk of developing back pain persists at least 30 months after discontinuation of teriparatide treatment: a meta-analysis
  Michael C. Nevitt, Peiqi Chen, Douglas P. Kiel, Jean-Yves Reginster, Robin K. Dore, J.R. Zanchetta, Emmett V. Glass, John H. Krege> ;Osteoporosis International. 2006 Aug 8
• 89 citations
  Reduced risk of back pain following teriparatide treatment: a meta-analysis.
  Michael C. Nevitt, Peiqi Chen, Robin K. Dore, Jean-Yves Reginster, Douglas P. Kiel, Jose R. Zanchetta, Emmett V. Glass, John H. Krege> ;Osteoporosis International. 2006 Feb 1
• 26 citations
  Concomitant medication use in a large, international, multicenter, placebo controlled trial of anakinra, a recombinant interleukin 1 receptor antagonist, in patients w...
  John Tesser, Roy Fleischmann, Robin Dore, Ralph Bennett, Alan M. Solinger, Tenshang Joh, Dennis Modafferi, Joy Schechtman> ;The Journal of Rheumatology. 2004 Apr 1
• 248 citations
  A randomized double-blind trial to compare the efficacy of teriparatide [recombinant human parathyroid hormone (1-34)] with alendronate in postmenopausal women with os...
  Jean-Jacques Body, Gregory A Gaich, Wim H. Scheele, Pandurang M. Kulkarni, Paul D. Miller, Anne Peretz, Robin K. Dore, Ricardo Correa-Rotter, Alexandra Papaioannou, Da...> ;The Journal of Clinical Endocrinology and Metabolism. 2002 Oct 1
• Osteoporosis in the elderly: a clinical perspective of current and future therapies.
  Dore, R.K., Hurley, D.J.> ;J Am Med Dir Assoc. 2002-07-01
• Join now to see all

Journal Articles

• Osteoporosis: Fractures and Key Risk Factors.  
  Dore RK, Female Patient; March Supp:5-12
• Guidelines for Rheumatology Referral.  
  Dore RK, et al, American College of Rheumatology
• Efficacy and Safety of Etodolac and Naproxen in Patients with Osteoarthritis of the Knee: A Double-Blind, Placebo Controlled Study.  
  Dore RK, et al, Clinical Therapeutics, Vol. 17, No 4, 656-666
• Generalized Morphia with Peripheral Eosinophilic Fasciitis and Myositis.  
  King DF, Dore RK, Gilbert DJ, Gurevitch AW, and Hirosi FM, Intemational J. DermatoI_19:149-154
• Join now to see all

Books/Book Chapters

• Arthritis: your comprehensive guide to pain management, medication, diet, exercise, surgery, and physical therapies. 
  Bird H, Green C et al. US Consultant: Dore RKDK Publishing, New York
• Bone Disease in Rheumatology. 
  Chapter: The Use of Parathyroid Hormone in Patients with Rheumatic Diseases 
  Dore RKEditors: Maricic MJ, Gluck 0.Lippincott Williams & Wilkins, Philadelphia, PA
• Treatment of the Rheumatic Disease. 
  Chapter: Developing Medical Documentation for Rheumatology Encounters 
  Locks CD, Dore RKEditors: Weisman M, Weinblatt M, Louie J.WB Saunders, Philadelphia, PAEdition 2nd,

Abstracts/Posters

• Denosumab Increases Bone Mineral Density in Patients With Rheumatoid Arthritis: 12-month Results.
  Dore R et al, ASBMR
• Inhibiting RANKL with Denosumab Increases Bone Mineral Density in Patients with Rheumatoid Arthritis: 6month results from a randomized, placebo-controlled study.
  Dore RK et al, EULAR
• RANKL Inhibition with Denosumab Increases Bone Mineral Density in Patients with Rheumatoid Arthritis.
  Dore RK et al, ECCEO, Porto, Portugal
• Denosumab Increases Bone Mineral Density in Patients With Rheumatoid Arthritis.
  Dore RK et ai, ACR, Washington, DC
• Reasons for Patient Preferences for Once-Monthly Ibandronate.
  Dore RK, ASBMR, Philadelphia, PA
• Patient Preferences with a Once-Monthly Bisphosphonate.
  Dore RK, Congress on Osteoporosis, Toronto
• Liquid Enbrel improves Function and Health Related Quality of Life for Patients with Rheumatoid Arthritis.
  Dore R, et al, EULAR, Vienna, Austria
• The Safety and Efficacy Profile of Etanercept (ENBREL) Liquid Administered Once Weekly in Patients With Rheumatoid Arthritis.
  RK Dore, et al, ACR Annual Scientific Meeting, San Antonio TX
• Reduced Risk of Back Pain following Teriparatide Treatment: A Meta-analysis.
  RK Dore, et al, ACR Annual Scientific Meeting, San Antonio TX
• Reduction in Back Pain following Teriparatide compared with Alendronate treatment of postmenopausal women with osteoporosis.
  RK Dore, JH Krege, P Chen et al, 31st European Symposium on Caloified Tissues, Nice, France
• The safety of anakinra in combination with other RA therapies.
  Tesser J, Schectman J, Dore R et al for the 757 Study Group, EULAR
• Cevimeiine for the treatment of xerostomia in patients with Sjogren syndrome: a randomized trial.
  Fife R, Chase WF, Dore RK et al, Arch /ntem Med
• Changes in Bone Mineral Density 18 Months After Cessation of Recombinant Human Parathyroid Hormone (1-34) or Alendronate Treatment in Postmenopausal Women.
  Dore RK, Hodsman AB, et al, ACR, San Francisco
• A Profile of Lymphocytotoxic Antibodies in Systemic Lupus Erythematosus.
  Dore RK, Nies, KM, lwaki Y, Louie JS, Terasaki P, Clinical Research
• A Profile of Lymphocytotoxic Antibodies in Systemic Lupus Erythematosus.
  Dore RK, Nies KM, lwaki Y, Louie JS, Terasaki P, American Rheumatism National Meetings, Atlanta, GA
• Join now to see all